ºÃÉ«ÏÈÉú

March 10, 2025

This article is a sponsorship benefit of top-tier Advocate level support of the AAN Leadership Development Programs.

The AAN and its Leadership Development Programs have found great partners in companies that share their priorities in neurology. AbbVie’s Manoj Malhotra, MD, Vice President, Global Medical Affairs, Neuroscience & Eye Care, Medical Affairs + Health Impact, believes the Leadership Development Programs cultivate principles core to AbbVie’s mission. 

Q. How do you feel the AAN Leadership Development Programs benefit the field of neurology overall?

A. As the global population ages, the prevalence of neurological conditions is increasing, leading more people to seek medical advice and diagnosis. With older adults more likely to require care, early intervention and disease management are becoming more common, necessitating a larger workforce to accommodate these needs. 

We at AbbVie believe the AAN Leadership Development programs offer essential opportunities to nurture the next generation of health care leaders. These leaders will advance innovative science that will benefit patients and communities now and in the years to come through neurological research and treatment breakthroughs and sustainability—ultimately building trust where science meets care. 

Q. How do the AAN Leadership Development Programs align with AbbVie’s mission, values, and initiatives? 

A. AAN Leadership Development Programs cultivate care, commitment, and credibility—principles that are at the core of AbbVie’s promise to improving patient outcomes and advancing health care.

In the field of neuroscience, with many tough-to-treat conditions and high unmet need, our scientists are relentless in their pursuit of raising the standards of care. We are continuously exploring innovative, disease-modifying approaches to address some of the most prevalent and serious conditions.